PH30464A - Crystalline carbapenem derivative - Google Patents

Crystalline carbapenem derivative

Info

Publication number
PH30464A
PH30464A PH47271A PH47271A PH30464A PH 30464 A PH30464 A PH 30464A PH 47271 A PH47271 A PH 47271A PH 47271 A PH47271 A PH 47271A PH 30464 A PH30464 A PH 30464A
Authority
PH
Philippines
Prior art keywords
carbapenem derivative
crystalline carbapenem
crystalline
derivative
pyrrolidinylthio
Prior art date
Application number
PH47271A
Other languages
English (en)
Inventor
Endo Roruro Miyauchi Masa Isao
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of PH30464A publication Critical patent/PH30464A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
PH47271A 1992-11-17 1993-11-16 Crystalline carbapenem derivative PH30464A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30688492 1992-11-17
JP17026793 1993-07-09

Publications (1)

Publication Number Publication Date
PH30464A true PH30464A (en) 1997-05-28

Family

ID=26493307

Family Applications (1)

Application Number Title Priority Date Filing Date
PH47271A PH30464A (en) 1992-11-17 1993-11-16 Crystalline carbapenem derivative

Country Status (20)

Country Link
US (1) US5424306A (fr)
EP (1) EP0599512B1 (fr)
JP (1) JP2848552B2 (fr)
KR (1) KR100236845B1 (fr)
CN (1) CN1036714C (fr)
AT (1) ATE178066T1 (fr)
AU (1) AU677235B2 (fr)
CA (1) CA2103223C (fr)
CZ (1) CZ280507B6 (fr)
DE (1) DE69324106T2 (fr)
DK (1) DK0599512T3 (fr)
ES (1) ES2131560T3 (fr)
FI (1) FI103576B (fr)
GR (1) GR3029975T3 (fr)
HU (1) HU219582B (fr)
IL (1) IL107596A (fr)
NO (1) NO304431B1 (fr)
NZ (1) NZ250201A (fr)
PH (1) PH30464A (fr)
TW (1) TW360657B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997041853A1 (fr) * 1996-05-09 1997-11-13 Sankyo Company, Limited Compositions de lutte contre helicobacter pylori contenant des derives de 1-methylcarbapenem en tant qu'ingredient actif
US7041660B2 (en) * 1999-07-06 2006-05-09 Sankyo Company, Limited Crystalline 1-methylcarbapenem derivatives
TWI250160B (en) 1999-07-06 2006-03-01 Sankyo Co Crystalline 1-methylcarbapenem compound
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
ITMI20012364A1 (it) * 2001-11-09 2003-05-09 Antibioticos Spa Processo di sintesi della cefixima via alchil-o arilsolfonati
EP2316468A1 (fr) 2002-02-22 2011-05-04 Shire LLC Système de distribution et méthodes de protection et d'administration de dextroamphetamine
WO2004035539A1 (fr) * 2002-10-18 2004-04-29 Meiji Seika Kaisha, Ltd. Procede destine a la fabrication de carbapenem et intermediaire utilise dans sa fabrication
US20070249827A1 (en) * 2004-06-02 2007-10-25 Sandoz Ag Meropenem Intermediatein in Crystalling Form
JP2009143808A (ja) * 2006-03-28 2009-07-02 Kaneka Corp メロペネム中間体の単離方法
ES2602566T3 (es) 2007-01-12 2017-02-21 Novartis Ag Proceso para preparar ácido 5-bifenil-4-amino-2-metil pentanoico

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68919508T2 (de) * 1988-04-01 1995-07-20 Sankyo Co 2-(Heterocyclylthio)carbapenemderivate, deren Herstellung und deren Verwendung als Antibiotika.
US5242914A (en) * 1988-04-01 1993-09-07 Sankyo Company, Limited 2-(heterocyclylthio) carbapenem derivatives, their preparation and their use as antibiotics
JPH0745499B2 (ja) * 1988-05-10 1995-05-17 三共株式会社 １―メチルカルバペネム誘導体
EP0462521A1 (fr) * 1990-06-19 1991-12-27 Takeda Chemical Industries, Ltd. Pénème cristallin, sa préparation et son utilisation

Also Published As

Publication number Publication date
GR3029975T3 (en) 1999-07-30
TW360657B (en) 1999-06-11
DK0599512T3 (da) 1999-10-11
CA2103223C (fr) 2002-09-24
CA2103223A1 (fr) 1994-05-18
AU5063193A (en) 1994-06-02
US5424306A (en) 1995-06-13
HK1011977A1 (en) 1999-07-23
HU219582B (hu) 2001-05-28
FI935063L (fi) 1994-05-18
CZ245493A3 (en) 1995-08-16
NO934140L (no) 1994-05-18
JPH07165759A (ja) 1995-06-27
ATE178066T1 (de) 1999-04-15
NZ250201A (en) 1995-04-27
DE69324106T2 (de) 1999-12-09
EP0599512A1 (fr) 1994-06-01
AU677235B2 (en) 1997-04-17
IL107596A0 (en) 1994-02-27
CN1093366A (zh) 1994-10-12
FI103576B1 (fi) 1999-07-30
NO934140D0 (no) 1993-11-16
JP2848552B2 (ja) 1999-01-20
KR100236845B1 (ko) 2000-02-01
NO304431B1 (no) 1998-12-14
KR940011463A (ko) 1994-06-21
HUT66001A (en) 1994-08-29
ES2131560T3 (es) 1999-08-01
FI103576B (fi) 1999-07-30
FI935063A0 (fi) 1993-11-16
EP0599512B1 (fr) 1999-03-24
CZ280507B6 (cs) 1996-02-14
DE69324106D1 (de) 1999-04-29
CN1036714C (zh) 1997-12-17
IL107596A (en) 1998-02-08

Similar Documents

Publication Publication Date Title
GR3029975T3 (en) Crystalline carbapenem derivative.
AU3427193A (en) Pyrimidin compounds useful as herbicides
CA2404703A1 (fr) Nouvelle forme cristalline d'un derive de pyrrolidylthiocarbapenem
CA2427762A1 (fr) Preparation de n-formimidoyl thienamycine monohydrate cristallin (imipenem monohydrate)
EP0480100A3 (en) Process for preparing (1r,5s,6s)-2-((6,7-dihydro-5h-pyrazolo(1,2-alpha)(1,2,4)triazolium-6-yl)thio-6-((r)-1-hydroxyethyl)-1-methyl-carbapenem-3-carboxylate and starting materials thereof
NZ332453A (en) (1R,5S,6S)-6-[(1R)-1-hydroxyethyl]-1-methyl-2-[(2S,4S)-2-[(3R)-3-methylaminomethylpyrrolidin-1-ylcarbonyl]pyrrolidin-4-ylthio]-1-carbapen-2-em-3-carboxylic acid for the prevention or treatment of bacterial infections
RU93051177A (ru) Кристаллическое производное карбапенема, способ получения, фармацевтическая композиция и способ лечения и/или профилактики
MY103733A (en) Methoxymethyl compounds
AU5186793A (en) Lens edging maching bevel control process
PT81411B (en) Process for preparing crystalline (5r,6s)-2-aminomethyl-6-<(1r)-1-hydroxyethyl>-2-penem-3-carboxylic acid
DE3880660D1 (en) In 2-stellung substituierte (1r,5s,6s)-2-thio-6-((r)-1-hydroxyethyl)-1-methyl-carbapenem-carbonsaeure-derivate.
ZA938438B (en) Crystalline carbapenem derivative
IE840795L (en) Novel penem compounds
AU7212687A (en) (5r,6s)-2-aminomethyl-6-((1r)-1-hydroxyethyl)-2-penem-3 carboxylic acid monohydrates
AU8660891A (en) 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds
EG18143A (en) Process for 2-(1-)xo-3-theiolanyl)-2-penem antibiotics
ZA9114B (en) Process for preparing(1r,5s,6s)-2-((6,7-dihydro-5h-pyrazolo(1,2-a)(1,2,4)triazolium-6-yl))thio-6-((r)-1-hydroxyethyl)-1-methyl-carbapenem-3-carboxylate and starting materials thereof
JPS6426580A (en) Production of carbapenem derivative
HK1058197A (en) Process for the preparation of crystalline n-formimidoyl thienamycin monohydrate (imipenem monohydrate)
TH10195B (th) อนุพันธ์คาร์แบเพแนมซึ่งเป็นผลึก